title: Hypothyroidism after iodine-131 or surgical therapy for Graves' disease hyperthyroidism.
abstract: BACKGROUND
  The aim of this work was to describe late permanent hypothyroidism after iodine-131 or surgery, and to seek predictive factors of hypothyroidism for the two treatments.
  
  
  METHODS
  From 1979 to 1994, 462 patients with Graves' disease hyperthyroidism underwent definitive treatment. Three hundred and fifty-five patients were treated with low calculated doses of iodine-131, and 107 patients with subtotal thyroidectomy. Life-table analysis was performed and the cumulative incidence of hypothyroidism was calculated by Kaplan-Meier's method, and survival (euthyroidism) within the groups was compared by the Mantel-Cox method.
  
  
  RESULTS
  Of the 355 patients treated with one dose of 6.6 1.9 mCi of iodine-131, 246 became euthyroid after one dose, and 109 needed 2 or more doses. Twenty-two patients received one or more doses higher than 10 mCi. The probability of euthyroidism at 145 months after low-dose was 10. 19% and age, sex, pretreatment with antithyroid drugs, previous subtotal surgery did not influence the final outcome. Of the 107 surgically treated patients the probability of euthyroidism at 144 months was 56.1%. Age, sex, duration of hyperthyroidism, duration of antithyroid treatment, weight of thyroid resected, did not influence the final outcome. The weight of the thyroid remnant was 5.4 1.5 g and the multivariate statistical model by conditional logistic regression showed that the weight of thyroid remnant was the only variable that influenced long-term thyroid function.
  
  
  CONCLUSIONS
  There is no ideal dose of iodine-131 that would correct hyperthyroidism in Graveś disease without risk of hypothyroidism. Surgery is an alternative definitive treatment with a risk of hypothyroidism within the 2 first years, and a cumulative risk of hypothyroidism lower than with iodine-131.
authors.affiliation: Services of Endocrinology and Surgery. Ciutat Sanitaria i Universitaria de Bellvitge. L'Hospitalet de Llobregat, Barcelona Spain.
authors.forename: J M
authors.initials: JM
authors.lastname: Gómez
authors.forename: N
authors.initials: N
authors.lastname: Gómez
authors.forename: M
authors.initials: M
authors.lastname: Amat
authors.forename: S
authors.initials: S
authors.lastname: Biondo
authors.forename: A
authors.initials: A
authors.lastname: Rafecas
authors.forename: E
authors.initials: E
authors.lastname: Jaurrieta
authors.forename: J
authors.initials: J
authors.lastname: Soler
mesh_terms: D000328:Adult; D000368:Aged; D000375:Aging; D005260:Female; D006111:Graves Disease / Q000532:radiotherapy* / Q000601:surgery*; D006801:Humans; D007037:Hypothyroidism / Q000209:etiology*; D007457:Iodine Radioisotopes / Q000009:adverse effects* / Q000627:therapeutic use; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D013965:Thyroidectomy / Q000009:adverse effects*; D013997:Time Factors
chemical_list: D007457:Iodine Radioisotopes